Hypoxic treatment of human dual placental perfusion induces a preeclampsia-like inflammatory response

Laboratory Investigation

Volumn 94, Issue 8, 2014, Pages 873-880

  Jain, Arjun ^a   Schneider, Henning ^a   Aliyev, Eldar ^a   Soydemir, Fatimah ^b,c   Baumann, Marc ^a   Surbek, Daniel ^a   Hediger, Matthias ^a   Brownbill, Paul ^b,c   Albrecht, Christiane ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ANGIOGENIC FACTOR; BIOLOGICAL MARKER; ENDOTHELIN 1; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MALONALDEHYDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; FETUS; HUMAN; HYPERTENSION; HYPOXIA; INFLAMMATION; MATERNAL BLOOD; OXIDATIVE STRESS; OXYGEN TENSION; PATHOPHYSIOLOGY; PLACENTA CIRCULATION; PLACENTA PERFUSION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; SYMPTOMATOLOGY; TROPHOBLAST; VENOUS BLOOD;

BIOLOGICAL MARKERS; CELL HYPOXIA; CYTOKINES; DINOPROST; ENDOTHELIN-1; FEMALE; HUMANS; KINETICS; LIPID PEROXIDATION; MALONDIALDEHYDE; OXIDATIVE STRESS; PERFUSION; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; UP-REGULATION;

EID: 84905181442     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2014.76     Document Type: Article

References (62)

1. Schneider H, Panigel M, Dancis J. Transfer across the perfused human placenta of antipyrine, sodium and leucine. Am J Obstet Gynecol 1972;114:822-828.
2. Dancis J. Why perfuse the human placenta. Contrib Gynecol Obstet 1985;13:1-4.
3. Leach L, Eaton BM, Westcott ED, et al. Effect of histamine on endothelial permeability and structure and adhesion molecules of the paracellular junctions of perfused human placental microvessels. Microvasc Res 1995;50:323-337.
4. Di Santo S, Sager R, Andres AC, et al. Dual in vitro perfusion of an isolated cotyledon as a model to study the implication of changes in the third trimester placenta on preeclampsia. Placenta 2007;28(Suppl A):S23-S32.
5. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999;222:222-235.
6. Lyall F. Priming and remodelling of human placental bed spiral arteries during pregnancy-a review. Placenta 2005;26(Suppl A):S31-S36.
7. Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 2006;27: 939-958.
8. Red-Horse K, Zhou Y, Genbacev O, et al. Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest 2004;114:744-754.
9. Redman CW, Sargent IL. Placental debris, oxidative stress and pre-eclampsia. Placenta 2000;21:597-602.
10. Sargent IL, Germain SJ, Sacks GP, et al. Trophoblast deportation and the maternal inflammatory response in pre-eclampsia. J Reprod Immunol 2003;59:153-160.
11. Hieda HS, Gomez-Sanchez CE. Hypoxia increases endothelin release in bovine endothelial cells in culture, but epinephrine, norepinephrine, serotonin, histamine and angiotensin II do not. Life Sci 1990;47:247-251.
12. Jain A. Endothelin-1: a key pathological factor in pre-eclampsia? Reprod Biomed Online 2012;25:443-449.
13. Jain A, Olovsson M, Burton GJ, et al. Endothelin-1 induces endoplasmic reticulum stress by activating the PLC-IP(3) pathway: implications for placental pathophysiology in preeclampsia. Am J Pathol 2012;180: 2309-2320.
14. George EM, Granger JP. Endothelin: key mediator of hypertension in preeclampsia. Am J Hypertens 2011;24:964-969.
15. Tam Tam KB, George E, Cockrell K, et al. Endothelin type A receptor antagonist attenuates placental ischemia-induced hypertension and uterine vascular resistance. Am J Obstet Gynecol 2011;204:e1-e4.
16. Fiore G, Florio P, Micheli L, et al. Endothelin-1 triggers placental oxidative stress pathways: putative role in preeclampsia. J Clin Endocrinol Metab 2005;90:4205-4210.
17. Soydemir F, Kuruvilla S, Brown M, et al. Adapting in vitro dual per-fusion of the human placenta to soluble oxygen tensions associated with normal and pre-eclamptic pregnancy. Lab Invest 2011;91: 181-189.
18. Zamudio S, Kovalenko O, Vanderlelie J, et al. Chronic hypoxia in vivo reduces placental oxidative stress. Placenta 2007;28:846-853.
19. Hung TH, Burton GJ. Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. Taiwan J Obstet Gynecol 2006;45:189-200.
20. Hung TH, Skepper JN, Burton GJ. In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol 2001;159:1031-1043.
21. Hung TH, Skepper JN, Charnock-Jones DS, et al. Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res 2002;90:1274-1281.
22. Roberts JM, Hubel CA. Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet 1999;354:788-789.
23. Burton GJ, Jauniaux E. Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig 2004;11:342-352.
24. Yung HW, Korolchuk S, Tolkovsky AM, et al. Endoplasmic reticulum stress exacerbates ischemia-reperfusion-induced apoptosis through attenuation of Akt protein synthesis in human choriocarcinoma cells. FASEB J 2007;21:872-884.
25. Gupta S, Aziz N, Sekhon L, et al. Lipid peroxidation and antioxidant status in preeclampsia: a systematic review. Obstet Gynecol Surv 2009;64:750-759.
26. Wu JJ. Lipid peroxidation in preeclamptic and eclamptic pregnancies. Eur J Obstet Gynecol Reprod Biol 1996;64:51-54.
27. Sampson MJ, Gopaul N, Davies IR, et al. Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyper-glycemia in type 2 diabetes. Diabetes Care 2002;25:537-541.
28. Braekke K, Harsem NK, Staff AC. Oxidative stress and antioxidant status in fetal circulation in preeclampsia. Pediatr Res 2006;60:560-564.
29. Burton GJ, Woods AW, Jauniaux E, et al. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 2009; 30:473-482.
30. Redman CW, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol 2010;63:534-543.
31. Saito S, Sakai M, Sasaki Y, et al. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol 1999;117:550-555.
32. Ramma W, Ahmed A. Is inflammation the cause of pre-eclampsia? Biochem Soc Trans 2011;39:1619-1627.
33. Bayram M, Bostanci MS, Celtemena MB, et al. Maternal inflammatory response in severe preeclamptic and preeclamptic pregnancies. J Clin Gynecol Obstet 2012;2:40-45.
34. Lamarca B, Brewer J, Wallace K. IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate? Int J Infereron Cytokine Mediator Res 2011;2011:59-64.
35. Shamshirsaz AA, Paidas M, Krikun G. Preeclampsia, hypoxia, thrombosis, and inflammation. J Pregnancy 2012;2012:374047.
36. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499-506.
37. Makris A, Xu B, Yu B, et al. Placental deficiency of interleukin-10 (IL-10) in preeclampsia and its relationship to an IL10 promoter polymorphism. Placenta 2006;27:445-451.
38. Rein DT, Breidenbach M, Honscheid B, et al. Preeclamptic women are deficient of interleukin-10 as assessed by cytokine release of trophoblast cells in vitro. Cytokine 2003;23:119-125.
39. Chatterjee P, Kopriva SE, Chiasson VL, et al. Interleukin-4 deficiency induces mild preeclampsia in mice. J Hypertens 2013;31:1414-1423.
40. LaMarca B, Speed J, Fournier L, et al. Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade. Hypertension 2008;52: 1161-1167.
41. LaMarca BB, Cockrell K, Sullivan E, et al. Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension 2005;46:82-86.
42. Fukuroda T, Fujikawa T, Ozaki S, et al. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun 1994;199:1461-1465.
43. Mondon F, Anouar A, Ferre F. Endothelin receptor subtypes in the microvillous trophoblastic membrane of early gestation and term human placentas. Eur J Endocrinol 1998;139:231-237.
44. Hemsen A, Gillis C, Larsson O, et al. Characterization, localization and actions of endothelins in umbilical vessels and placenta of man. Acta Physiol Scand 1991;143:395-404.
45. Rius J, Guma M, Schachtrup C, et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008;453:807-811.
46. Hubel CA. Dyslipidemia, iron, and oxidative stress in preeclampsia: assessment of maternal and feto-placental interactions. Semin Reprod Endocrinol 1998;16:75-92.
47. Vadillo-Ortega F, Perichart-Perera O, Espino S, et al. Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial. BMJ 2011;342:d2901.
48. Hensley K, Robinson KA, Gabbita SP, et al. Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med 2000;28:1456-1462.
49. Huang X, Jain A, Baumann M, et al. Increased placental phospholipid levels in pre-eclamptic pregnancies. Int J Mol Sci 2013;14:3487-3499.
50. Yanik FF, Amanvermez R, Yanik A, et al. Pre-eclampsia associated with increased lipid peroxidation and decreased serum vitamin E levels. Int J Gynaecol Obstet 1999;64:27-33.
51. Barden A, Beilin LJ, Ritchie J, et al. Plasma and urinary 8-iso-prostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancy. Clin Sci (Lond) 1996;91:711-718.
52. Roberts LJ, Morrow JD. Measurement of F-2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000;28:505-513.
53. Walsh SW. Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Semin Reprod Endocrinol 1998;16:93-104.
54. Walsh SW, Vaughan JE, Wang Y, et al. Placental isoprostane is significantly increased in preeclampsia. FASEB J 2000;14:1289-1296.
55. Walsh SW, Vaughan JE, Wang Y, et al. Placental isoprostane is significantly increased in preeclampsia. FASEB J 2000;14:1289-1296.
56. Mandang S, Manuelpillai U, Wallace EM. Oxidative stress increases placental and endothelial cell activin A secretion. J Endocrinol 2007;192:485-493.
57. Ahmed A. Heparin-binding angiogenic growth factors in pregnancy. Placenta 1997;18:215-258.
58. Ramma W, Ahmed A. Is inflammation the cause of pre-eclampsia? Biochem Soc Trans 2011;39:1619-1627.
59. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-683.
60. Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 2008;51:970-975.
61. Huppertz B, Sammar M, Chefetz I, et al. Longitudinal determination of serum placental protein 13 during development of preeclampsia. Fetal Diagn Ther 2008;24:230-236.
62. Baumann MU, Bersinger NA, Mohaupt MG, et al. First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia. Am J Obstet Gynecol 2008;199:e1-e6.